ARTICLE | Company News
Archemix, Noxxon deal
January 7, 2002 8:00 AM UTC
Noxxon paid $5 million to Archemix for a global exclusive sublicense to use part of Archemix's systemic evolution of ligands through exponential enrichment (SELEX) aptamer identification technology. N...